Clinical and genetic characterization of neuronal ceroid lipofuscinoses (NCLs) in 29 Iranian patients: identification of 11 novel mutations.

[1]  J. Paprocka,et al.  Recent Insight into the Genetic Basis, Clinical Features, and Diagnostic Methods for Neuronal Ceroid Lipofuscinosis , 2022, International journal of molecular sciences.

[2]  A. Simonati,et al.  Neuronal Ceroid Lipofuscinosis: The Multifaceted Approach to the Clinical Issues, an Overview , 2022, Frontiers in Neurology.

[3]  J. Weimer,et al.  On the cusp of cures: Breakthroughs in Batten disease research , 2021, Current Opinion in Neurobiology.

[4]  S. Mole,et al.  The Genetic Basis of Phenotypic Heterogeneity in the Neuronal Ceroid Lipofuscinoses , 2021, Frontiers in Neurology.

[5]  Christopher G Chute,et al.  The Human Phenotype Ontology in 2021 , 2020, Nucleic Acids Res..

[6]  Amanda M. Morrill,et al.  Review of Cerliponase Alfa: Recombinant Human Enzyme Replacement Therapy for Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2 , 2019, Journal of child neurology.

[7]  A. Mukherjee,et al.  Emerging new roles of the lysosome and neuronal ceroid lipofuscinoses , 2019, Molecular Neurodegeneration.

[8]  A. Markham,et al.  Cerliponase Alfa: First Global Approval , 2017, Drugs.

[9]  D. Trujillano,et al.  A comprehensive global genotype–phenotype database for rare diseases , 2016, Molecular genetics & genomic medicine.

[10]  Jinchuan Xing,et al.  Analysis of large-scale whole exome sequencing data to determine the prevalence of genetically-distinct forms of neuronal ceroid lipofuscinosis. , 2016, Gene.

[11]  D. A. Nita,et al.  Neuronal ceroid lipofuscinoses. , 2016, Epileptic disorders : international epilepsy journal with videotape.

[12]  T. Kielian,et al.  Moving towards effective therapeutic strategies for Neuronal Ceroid Lipofuscinosis , 2016, Orphanet Journal of Rare Diseases.

[13]  S. Mole,et al.  Genetics of the neuronal ceroid lipofuscinoses (Batten disease). , 2015, Biochimica et biophysica acta.

[14]  Xiaomin Liu,et al.  A novel CLN2/TPP1 mutation in a patient with late infantile neuronal ceroid lipofuscinosis , 2015, Neurological Sciences.

[15]  A. Ballabio,et al.  Lysoplex: An efficient toolkit to detect DNA sequence variations in the autophagy-lysosomal pathway , 2015, Autophagy.

[16]  Siddharth Srivastava,et al.  Clinical whole exome sequencing in child neurology practice , 2014, Annals of neurology.

[17]  M. Behari,et al.  Novel mutations in typical and atypical genetic loci through exome sequencing in autosomal recessive cerebellar ataxia families , 2014, Clinical genetics.

[18]  V. Warrier,et al.  Genetic basis and phenotypic correlations of the neuronal ceroid lipofusinoses. , 2013, Biochimica et biophysica acta.

[19]  H. Goebel,et al.  The neuronal ceroid-lipofuscinoses: a historical introduction. , 2013, Biochimica et biophysica acta.

[20]  A. Jalanko,et al.  Cell biology and function of neuronal ceroid lipofuscinosis-related proteins. , 2013, Biochimica et biophysica acta.

[21]  J. Cooper,et al.  Pathogenesis and Therapies for Infantile Neuronal Ceroid Lipofuscinosis (infantile Cln1 Disease) Hhs Public Access , 2022 .

[22]  J. Mink,et al.  Classification and Natural History of the Neuronal Ceroid Lipofuscinoses , 2013, Journal of child neurology.

[23]  K. Sims,et al.  Neuronal Ceroid Lipofuscinosis: Impact of Recent Genetic Advances and Expansion of the Clinicopathologic Spectrum , 2013, Current Neurology and Neuroscience Reports.

[24]  M. Kousi,et al.  Update of the mutation spectrum and clinical correlations of over 360 mutations in eight genes that underlie the neuronal ceroid lipofuscinoses , 2012, Human mutation.

[25]  C. van Broeckhoven,et al.  Mutations in DNAJC5, encoding cysteine-string protein alpha, cause autosomal-dominant adult-onset neuronal ceroid lipofuscinosis. , 2011, American journal of human genetics.

[26]  Katherine R. Smith,et al.  Kufs disease, the major adult form of neuronal ceroid lipofuscinosis, caused by mutations in CLN6. , 2011, American journal of human genetics.

[27]  M. DePristo,et al.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.

[28]  Richard Durbin,et al.  Fast and accurate long-read alignment with Burrows–Wheeler transform , 2010, Bioinform..

[29]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[30]  B. Minassian,et al.  Mutations in CLN7/MFSD8 are a common cause of variant late-infantile neuronal ceroid lipofuscinosis. , 2009, Brain : a journal of neurology.

[31]  Charles A. Nelson,et al.  A Neurobiological Perspective on Early Human Deprivation , 2007 .

[32]  D. Pearce,et al.  You say lipofuscin, we say ceroid: Defining autofluorescent storage material , 2006, Neurobiology of Aging.

[33]  H. Goebel,et al.  Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses , 2005, Neurogenetics.

[34]  S. Mole.  The Genetic Spectrum of Human Neuronal Ceroid‐lipofuscinoses , 2004, Brain pathology.

[35]  S. Mole,et al.  Spectrum of CLN6 mutations in variant late infantile neuronal ceroid lipofuscinosis , 2003, Human mutation.

[36]  M. Haltia.  The Neuronal Ceroid–Lipofuscinoses , 2003, Journal of neuropathology and experimental neurology.

[37]  V. Petruzzella,et al.  A novel insertion mutation (A169i) in the CLN1 gene is associated with infantile neuronal ceroid lipofuscinosis in an Italian patient. , 1998, Biochemical and biophysical research communications.

[38]  R. Donnelly,et al.  Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis. , 1997, Science.

[39]  P. Dyken,et al.  Neuronal ceroid-lipofuscinosis (Batten's disease): relationship to amaurotic family idiocy? , 1969, Pediatrics.